Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria 26.01.21 | Meir Orbach
Omnix Medical completes $8.5 million round to develop next-generation antibiotics for treatment of life-threatening infections 03.11.20 | Meir Orbach